Secret secrets are no fun, especially when they’re stolen trade secrets with big money on the line. But for two former GSK researchers, their sentences for trade secrets theft will remain somewhat brief.
After pleading guilty in 2018 to stealing trade secrets on potential cancer drugs, a unanimous panel of the U.S. Court of Appeals for the Third Circuit upheld the previously set sentences of former GSK researchers Yu Xue and Tao Li.
Xue has already served eight months, while Li has served a 59-day sentence. Prosecutors wanted 10 years for Xue and seven for Li, Reuters reports.
With the appeals ruling, the former GSK researchers will have fulfilled their sentences.
The court found that the defendants did not intend to harm GSK financially, so it decided against extending their sentences.